• In the lead-up to Mirion Technologies’ June 2026 quarter results, analysts had been expecting lower year-on-year earnings despite higher revenues, with forecasts last updated before the announcement.
• An interesting shift has been that the Most Accurate Estimate recently moved above the broader Zacks Consensus Estimate, signalling a late upswing in analyst optimism around Mirion’s earnings outlook.
• We’ll now explore how this more optimistic analyst earnings stance could influence Mirion Technologies’ broader investment narrative and risk-reward profile.

AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Mirion Technologies Investment Narrative Recap

To hold Mirion Technologies, you need to believe in sustained demand for radiation detection across nuclear, medical and research markets, supported by modernization and compliance needs. The recent uptick in analyst earnings expectations ahead of the June 2026 quarter does not materially change the core near term catalyst around nuclear project execution, nor the central risk from potential long term pressure on nuclear build pipelines and policy.

The recent additions of Mirion to multiple Russell indexes in June 2026 look most relevant here, as they can influence trading activity and how quickly sentiment shifts around earnings revisions. Index inclusion sits alongside prior moves like the Vital software rollout and the Certrec acquisition, which together frame the key catalyst of growing higher margin, software enabled revenue tied to long dated nuclear and compliance projects.

Yet, despite this more optimistic analyst earnings tone, investors should be aware of the longer term risk that...

Mirion Technologies' narrative projects $1.4 billion revenue and $145.5 million earnings by 2029. This requires 11.9% yearly revenue growth and about a $120 million earnings increase from $25.1 million today.

Uncover how Mirion Technologies' forecasts yield a $27.90 fair value, a 71% upside to its current price.

Exploring Other Perspectives

Four members of the Simply Wall St Community estimate Mirion’s fair value between US$15.14 and US$27.90, highlighting very different individual views. You can weigh those against the current focus on nuclear modernization and life extensions, which is central to Mirion’s opportunity but also linked to policy and project cycle risks that could influence future performance.

Explore 4 other fair value estimates on Mirion Technologies - why the stock might be worth as much as 71% more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Mirion Technologies research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Mirion Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Mirion Technologies' overall financial health at a glance.

Curious About Other Options?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
• Outshine the giants: these 16 early-stage AI stocks could fund your retirement.
• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 29 best rare earth metal stocks of the very few that mine this essential strategic resource.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.